New initiative aims to accelerate diagnosis and ease NHS pressures More: Chiesi partners with Wirral Primary Care to improve COPD detection Source: News
read more
Company seeks approval for new schedules to improve patient convenience More: Johnson & Johnson submits application for subcutaneous Rybrevant dosing Source: News
read moreBristol Myers Squibb plans to invest $40 billion across U.S. R&D, technology and manufacturing over the next five years, CEO Chris Boerner said in an op-ed published by Stat this week. More: 'Now is not the time to retreat': BMS
read moreIn President Donald Trump’s latest push to bring pharmaceutical manufacturing to the U.S., a new executive order tasks the FDA with reducing regulatory hurdles for domestic producers while making life harder for foreign manufacturers. More: Trump signs executive order to
read moreA little over a month after announcing her departure from Moderna, Kate Cronin has begun her “next adventure.” More: Ex-Moderna brand chief Kate Cronin joins Medtronic Diabetes as marketing head Source: fierce
read moreAfter a 2024 in which AbbVie’s Skyrizi boasted the highest TV drug ad spending outlay on seven of our monthly roundups—and took second place in four more—the immunology med has seen that dominance slip in 2025. More: AbbVie’s Skyrizi retakes
read more© 1994 - 2026 B.M. Pharmaceuticals